Eliquis Lawsuit

Contact A Lawyer

Have A Potential Case Reviewed By An Attorney

  • This field is for validation purposes and should be left unchanged.

Eliquis is part of a new-generation of oral anticoagulants. However, side effects of Eliquis have been linked to reports of severe and uncontrollable bleeding due to the lack of an effective reversal agent at the time the medication was introduced.

STATUS OF ELIQUIS BLEEDING LAWSUITS: Product liability lawyers are reviewing whether former users who have experienced hemorrhages, gastrointestinal bleeding, strokes or wrongful death may be entitled to financial compensation through an Eliquis lawsuit.


MANUFACTURER: Bristol Myers-Squibb

OVERVIEW: Eliquis (apixaban) was introduced in 2012 as the third member of a new class of anticoagulants used to reduce the risk of blood clots and strokes, particularly among patients with atrial fibrillation.

Known as a “direct thrombin inhibitor” or “Factor Xa inhibitor,” Eliquis was designed to compete with Boehringer Ingelheim’s Pradaxa, as well as Bayer and Johnson & Johnson’s Xarelto. All three drugs were released in an effort to replace the blood thinner warfarin, also known as Coumadin, which has dominated the atrial fibrillation blood thinner market for several decades.

Unlike warfarin, the three new drugs, Eliquis, Pradaxa, and Xarelto, lacked a reversal agent that can quickly counteract their blood thinning effects when they were first released. This has led to a number of reports of uncontrollable bleeding events resulting in severe injury or death.

A reversal agent for Pradaxa, Praxbind, became available in March 2016, however, the FDA rejected approval of a reversal agent for Eliquis and Xarelto in September 2016 until they can answer a number of the agency’s concerns.

A February 2017 study linked Eliquis side effects to a higher risk of strokes and embolism when compared to other blood thinners.

FIND OUT IF YOU MAY QUALIFY FOR A ELIQUIS LAWSUIT: As a result of the drug makers’ failure to adequately warn about the risks associated with their medication, Eliquis injury lawyers are evaluating whether users may be entitled to compensation through a product liability lawsuit.

Cases allege that Bristol Myers-Squibb withheld important safety information about the bleeding risk and the lack of an effective reversal agent. In addition, claims indicate that risk of injury outweighs any potential benefit provided by Eliquis, making the drug unreasonably dangerous and defective as it was originally formulated.

To request a free consultation and claim evaluation to determine whether you, a friend or family member may be entitled to financial compensation through a lawsuit, submit information for review by an Eliquis injury lawyer.

Tags: , ,


  1. Sue Reply

    While on Eloquis I’ve experienced horrific hair loss and subsequent thinning. The itching on my scalp has been relentless.

  2. tom Reply

    In hospital as my head is bleeding. Took me of the Eliques. I called ambulance and went to Hospital 6 times because I was passing OUT.

  3. Cathy Reply

    My mother was on Eliquis for two weeks and died from a massive, uncontrollable hemorrhage. She never had a bleeding disorder before taking this drug.

  4. Mark Reply

    I was on Eliquise for six weeks at age 54 and woke to terrible lower stomach pain , a few hours later I was rushed into surgery an was found to be bleeding from the small vessels in my pancreas , my surgeon stopped the bleed , he said if I wasent in an auto accident the bleed resulted from the blood thinner! I was never given an option, just put on Eliquise, for 8 mounth before the Eliquise I was on savaysa, due to my heart ablation

  5. Peter Reply

    Eliquise is suppose to prevent strokes I took the drug twice a day and had a stroke, while in rehab I asked other patients what they were taking and theyalmost all were taking Eliquise including a person who shared a hospital room who had a 2nd stroke while on the drug

  6. Patricia Reply

    I was on Eliquis for approximately 3 weeks starting on 3/15/19. I discontinued the medication because it affected my hemorrhoids. However, I continue to experience problems with my bowels (its now May 2019), and muscles in my lower body. As well as my spine – so much- that it is painful for me to drive my car.

  7. Jose Reply

    I took Eliquis due to a blood clot on my leg. After one month of taking the meds I had a brain bleed and multiple brain surgery. I am now on Dialysis and can’t work anymore.

  8. Paige Reply

    My father passed away on 7.27.19 at the age of 75 of a non traumatic intracranial hemorrhage while taking Elquis. Healthy one minute gone the next. No symptoms to cause any alarm but found unresponsive one morning and died the next day.

  9. Hunter Reply

    My grandmother passed away 1-20-2020. She had been hospitalized the previous week for trouble breathing. My grandmother has never had AFib nor was she at risk for stroke. The hospital administered the drug anyway. My grandmother wasn’t even home a week and was complaining of diarrhea and bloating. My mother found my grandmother unresponsive at 1:30 am and called an ambulance. When arriving at the hospital they had to then put my grandmother on 3 ventilators to keep her alive. When doing this they found my grandmother’s lungs and gut to be full of blood. I believe she suffered from a severe internal gastrointestinal bleed that went unnoticed because my grandmother had never had a problem with the clotting of her blood. I believe eliquis killed my grandmother.

  • Share Your Comments

  • Have Your Comments Reviewed by a Lawyer

    Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.
  • NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.
Contact A Lawyer

Contact A Lawyer

Have A Potential Case Reviewed By An Attorney

  • This field is for validation purposes and should be left unchanged.